764 / 1224
/
Systematic review of SBRT for centrally located
NSCLC
M Guckenberger - SBRT stage I NSCLC - HICARE 2015
22
Publications
22
Centrally located tumors
563
Stage I NSCLC
315
LC for BED
≧
100 Gy
≧
85%
G 3 / 4 toxicity
9%
Overall Tx related mortality
2.7%
Tx related mortality BED <210Gy
1.0%
8 x 7.5Gy
5 x 10Gy
3 x 13Gy
• Acceptable therapeutic ratio of more fractionated SBRT